CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 64 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 16,868 | -95.3% | 0.00% | -100.0% |
| Q3 2022 | $60,000 | -37.5% | 362,544 | +286.9% | 0.00% | 0.0% |
| Q3 2021 | $96,000 | -27.8% | 93,705 | +29.1% | 0.00% | 0.0% |
| Q2 2021 | $133,000 | +77.3% | 72,601 | +91.0% | 0.00% | 0.0% |
| Q1 2021 | $75,000 | -21.1% | 38,005 | +234.6% | 0.00% | -50.0% |
| Q2 2020 | $95,000 | +61.0% | 11,359 | +4.2% | 0.00% | +100.0% |
| Q4 2019 | $59,000 | -55.3% | 10,897 | -42.9% | 0.00% | -80.0% |
| Q2 2019 | $132,000 | – | 19,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $39,000 | 0.00% |